Sign In
Buy GMAB
$23.88
+0.0300 (+0.126%)
At Close: Jun 03, 2026
Genmab A/S 2020 Q2 - Results - Earnings Call Presentation
09:18am, Thursday, 13'th Aug 2020
The following slide deck was published by Genmab A/S in conjunction with their 2020 Q2 earnings call.
Genmab A/S (GMAB) Q2 2020 Earnings Call Transcript
02:30am, Thursday, 13'th Aug 2020
GMAB earnings call for the period ending June 30, 2020.
Genmab A/S (GMAB) CEO Jan van de Winkel on Q2 2020 Results - Earnings Call Transcript
11:51pm, Wednesday, 12'th Aug 2020
Genmab A/S (NASDAQ:GMAB) Q2 2020 Results Conference Call August 12, 2020 12:00 PM ET Company Participants Jan van de Winkel - President & CEO Anthony Pagano - CFO Judith Klimovsky - CDO Anthony Ma
Genmab Announces Financial Results for the First Half of 2020
03:23pm, Wednesday, 12'th Aug 2020
August 12, 2020; Copenhagen, Denmark; Interim Report for the First Half of 2020Highlights ·Genmab and AbbVie enter into broad oncology collaboration; USD 750 million upfront payment with t
Genmab (GMAB) to Report Q2 Earnings: What's in the Cards?
03:11pm, Monday, 03'rd Aug 2020
Genmab's (GMAB) second-quarter revenues are likely to have been driven by royalties on sales of J&J's Darzalex. Several pipeline candidates are under development.
AbbVie Shares Climb After Adjusted Profit Beats Analyst Views
01:47pm, Friday, 31'st Jul 2020
AbbVie's adjusted profit beat estimates. Revenue from the immunology and oncology portfolios saw gains in the second quarter.
Major Shareholder Announcement
03:57pm, Monday, 20'th Jul 2020
Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; July 20, 2020 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of.
Genmab Announces Net Sales of DARZALEX® for the Second Quarter of 2020
10:43am, Thursday, 16'th Jul 2020
Company Announcement Net sales of DARZALEX® in the second quarter of 2020 totaled USD 901 millionGenmab will receive royalties on worldwide net sales from Janssen Biotech, Inc..
Genmab's Shares March Higher, Can It Continue?
12:37pm, Friday, 10'th Jul 2020
As of late, it has definitely been a great time to be an investor in Genmab.
5 Booming Biotech Stocks to Buy
04:36pm, Friday, 03'rd Jul 2020
These five biotech stocks have already gone on heaters of 30% or more in 2020, and all of them still have plenty of upside to spare.
Hedge Funds Keep Buying Genmab A/S (GMAB)
04:32pm, Friday, 26'th Jun 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Can Genmab AS Sponsored ADR (GMAB) Run Higher on Rising Earnings Estimates?
04:20pm, Tuesday, 16'th Jun 2020
Genmab AS Sponsored ADR (GMAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
AbbVie Inks Deal With Genmab, Announces ADC Candidate Data
02:56pm, Thursday, 11'th Jun 2020
AbbVie (ABBV) signs deal with Genmab to jointly develop three early-stage bispecific antibody product candidates. Its novel ADC candidate, ABBV-3373 demonstrates clinical activity in study.
3 Wins for AbbVie in 3 Days Provide 3 More Good Reasons to Buy the Pharma Stock
11:01am, Thursday, 11'th Jun 2020
It then announced two positive developments on Wednesday, just in time for the company's top executives to participate in a virtual fireside chat at the Goldman Sachs annual healthcare conference. He
This Biotech Just Hit Pay Dirt On A Potential $3 Billion Deal With AbbVie
09:10pm, Wednesday, 10'th Jun 2020
Shares of Genmab popped Wednesday after the biotech inked a deal with pharma giant AbbVie to develop cancer treatments. The deal is potentially worth billions in milestone payments.
